We are live on ! Find out more
TNXP icon

Tonix Pharmaceuticals
TNXP

18 hedge funds and large institutions have $4.51M invested in Tonix Pharmaceuticals in 2023 Q1 according to their latest regulatory filings, with 1 funds opening new positions, 10 increasing their positions, 5 reducing their positions, and 5 closing their positions.

New
Increased
Maintained
Reduced
Closed

100% more repeat investments, than reductions

Existing positions increased: 10 | Existing positions reduced: 5

24% more capital invested

Capital invested by funds: $3.63M → $4.51M (+$879K)

0% less ownership

Funds ownership: 0% → 0% (-0%)

18% less funds holding

Funds holding: 22 → 18 (-4)

80% less first-time investments, than exits

New positions opened: 1 | Existing positions closed: 5

Holders
18
Holders Change
-4
Holders Change %
-18.18%
% of All Funds
0.29%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
1
Increased
10
Reduced
5
Closed
5
Calls
–
Puts
–
Net Calls
–
Net Calls Change
–

Top Buyers

Rank Fund Capital Flow
1
Vanguard Group
Vanguard Group
Pennsylvania
+$1.24M
2
Morgan Stanley
Morgan Stanley
New York
+$429K
3
JP Morgan Chase
JP Morgan Chase
New York
+$223K
4
Geode Capital Management
Geode Capital Management
Massachusetts
+$137K
5
State Street
State Street
Massachusetts
+$137K

Top Sellers

Rank Fund Capital Flow
1
TCM
Tang Capital Management
California
-$2.92M
2
Acadian Asset Management
Acadian Asset Management
Massachusetts
-$635K
3
VF
Virtu Financial
New York
-$103K
4
TSS
Two Sigma Securities
New York
-$34.3K
5
UBS Group
UBS Group
Switzerland
-$34.3K
Name Holding Trade Value Shares
Change 		Change in
Stake
FWM
26
Focused Wealth Management
New York
$131 – – –
FDCDDQ
27
Federation des caisses Desjardins du Quebec
Quebec, Canada
$93 – – –
BHWM
28
Beaird Harris Wealth Management
Texas
$47 – – –
GI
29
Gradient Investments
Minnesota
$37 – – –
Commonwealth Equity Services
30
Commonwealth Equity Services
Massachusetts
$22 – – –
NSIM
31
North Star Investment Management
Illinois
$22 – – –
IA
32
IFP Advisors
Florida
$15 – – –
TLCM
33
Twin Lakes Capital Management
California
$11 – – –
GWSA
34
Global Wealth Strategies & Associates
Colorado
$10 – – –
ASN
35
Advisory Services Network
Georgia
$1 – – –
HIA
36
Harbor Investment Advisory
Maryland
$1 – – –
New York State Common Retirement Fund
37
New York State Common Retirement Fund
New York
$1 – – –
TCM
38
Tradewinds Capital Management
Washington
$1 – – –
CCM
39
Condor Capital Management
New Jersey
– -$3.9K -1 Closed
ETC
40
Exchange Traded Concepts
Oklahoma
– -$9.03K -1 Closed
Jane Street
41
Jane Street
New York
– -$5.94K -1 Closed
Millennium Management
42
Millennium Management
New York
– -$5K -1 Closed
SG
43
StoneX Group
New York
– -$4.96K -1 Closed
AF
44
Allworth Financial
California
– -$390 – –
1
2

TNXP Hedge Fund Activity: Q1 2023 in Review

18 of the 6,275 institutional investors tracked by Wall St. Rank reported a position in Tonix Pharmaceuticals (TNXP) for Q1 2023, worth a combined $4.51M — up 24% from $3.63M a quarter earlier.

Sellers outnumbered buyers: 5 funds closed out of TNXP and 1 opened new positions — a net loss of 4 holders — while 5 trimmed existing stakes and 10 added.

The largest buyer was Vanguard Group, adding an estimated $1.24M. The largest seller was Tang Capital Management, cutting an estimated $2.92M.

  • 18 institutional investors held Tonix Pharmaceuticals (TNXP) as of Q1 2023, down from 22 in Q4 2022.
  • Funds reported $4.51M of Tonix Pharmaceuticals stock for Q1 2023, up 24% quarter-over-quarter.
  • 1 fund opened new Tonix Pharmaceuticals positions in Q1 2023 and 5 closed out, a net change of -4 holders.
  • The largest Tonix Pharmaceuticals buyer in Q1 2023 was Vanguard Group, an estimated $1.24M added.
  • The largest Tonix Pharmaceuticals seller in Q1 2023 was Tang Capital Management, an estimated $2.92M sold.

Based on aggregated 13F filings for Q1 2023.